Visiomed Group Past Earnings Performance

Past criteria checks 0/6

Visiomed Group has been growing earnings at an average annual rate of 37.1%, while the Medical Equipment industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 3.2% per year.

Key information

37.1%

Earnings growth rate

89.6%

EPS growth rate

Medical Equipment Industry Growth21.6%
Revenue growth rate3.2%
Return on equity-15.5%
Net Margin-29.4%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Is Visiomed Group (EPA:ALVMG) Using Too Much Debt?

Oct 13
Is Visiomed Group (EPA:ALVMG) Using Too Much Debt?

Visiomed Group (EPA:ALVMG) Is Carrying A Fair Bit Of Debt

Jun 03
Visiomed Group (EPA:ALVMG) Is Carrying A Fair Bit Of Debt

Revenues Not Telling The Story For Visiomed Group SA (EPA:ALVMG) After Shares Rise 37%

Apr 18
Revenues Not Telling The Story For Visiomed Group SA (EPA:ALVMG) After Shares Rise 37%

Here's Why We're Not Too Worried About Visiomed Group's (EPA:ALVMG) Cash Burn Situation

Mar 03
Here's Why We're Not Too Worried About Visiomed Group's (EPA:ALVMG) Cash Burn Situation

Revenue & Expenses Breakdown
Beta

How Visiomed Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALVMG Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2312-450
31 Mar 2313-450
31 Dec 2214-550
30 Sep 2215-440
30 Jun 2216-340
31 Mar 2211-440
31 Dec 217-430
30 Sep 214-730
30 Jun 211-930
31 Mar 2110-740
31 Dec 2019-540
30 Sep 2021-950
30 Jun 2022-1260
31 Mar 2016-1870
31 Dec 1910-2490
30 Sep 1911-24100
30 Jun 1911-23110
31 Mar 1910-21100
31 Dec 189-20100
30 Sep 189-1890
30 Jun 189-1680
31 Mar 1810-1480
31 Dec 1710-1370
30 Sep 1710-1470
30 Jun 1710-1560
31 Mar 1710-1460
31 Dec 169-1360
30 Sep 1610-1160
30 Jun 1610-950
31 Mar 1610-850
31 Dec 1511-750
30 Sep 1512-650
30 Jun 1514-540
31 Mar 1514-440
31 Dec 1413-340
30 Sep 1412-340
30 Jun 1410-440
31 Mar 1410-340
31 Dec 1311-340
30 Sep 1312-240
30 Jun 1313-240

Quality Earnings: ALVMG is currently unprofitable.

Growing Profit Margin: ALVMG is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALVMG is unprofitable, but has reduced losses over the past 5 years at a rate of 37.1% per year.

Accelerating Growth: Unable to compare ALVMG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALVMG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.2%).


Return on Equity

High ROE: ALVMG has a negative Return on Equity (-15.5%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.